Literature DB >> 8635664

Endosulfine, endogenous ligand for the sulphonylurea receptor: isolation from porcine brain and partial structural determination of the alpha form.

A Virsolvy-Vergine1, G Salazar, R Sillard, L Denoroy, V Mutt, D Bataille.   

Abstract

Anti-diabetic sulphonylureas act via high affinity binding sites coupled to K-ATP channels. Endosulfine, an endogenous ligand for these binding sites, was shown to exist in two molecular forms, alpha and beta, in both the pancreas and the central nervous system. We describe here the isolation, and partial structural characterization of alpha endosulfine derived from porcine brains by means of a series of chromatography runs and gel electrophoresis. Porcine alpha endosulfine is a protein with a molecular mass of 13,196 daltons as determined by mass spectrometry and which is N-terminally blocked. Tryptic digestion followed by separation of the fragments by HPLC and automated Edman degradation yielded a total of 72 amino acids in four partial sequences. Comparison of these sequences with that present in the National Biomedical Research Foundation protein data bank indicated a 82% identity with a 112-amino acid protein with a molecular mass of 12,353 daltons called "cyclic AMP-regulated phosphoprotein-19', isolated from the bovine brain as a substrate for protein kinase A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635664     DOI: 10.1007/bf00403955

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

Review 1.  The sulfonylurea receptor.

Authors:  S J Ashcroft; F M Ashcroft
Journal:  Biochim Biophys Acta       Date:  1992-12-15

Review 2.  Properties and functions of ATP-sensitive K-channels.

Authors:  S J Ashcroft; F M Ashcroft
Journal:  Cell Signal       Date:  1990       Impact factor: 4.315

Review 3.  Adenosine triphosphate-sensitive potassium channels in the cardiovascular system.

Authors:  C G Nichols; W J Lederer
Journal:  Am J Physiol       Date:  1991-12

4.  Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions.

Authors:  J A Girault; A Horiuchi; E L Gustafson; N L Rosen; P Greengard
Journal:  J Neurosci       Date:  1990-04       Impact factor: 6.167

5.  Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices.

Authors:  C Mourre; Y Ben Ari; H Bernardi; M Fosset; M Lazdunski
Journal:  Brain Res       Date:  1989-05-01       Impact factor: 3.252

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Polypeptide microsequence analysis with the commercially available gas-phase sequencer.

Authors:  F S Esch
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

8.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

9.  Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain.

Authors:  A Virsolvy-Vergine; H Leray; S Kuroki; B Lupo; M Dufour; D Bataille
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

10.  Purification and cDNA cloning of ARPP-16, a cAMP-regulated phosphoprotein enriched in basal ganglia, and of a related phosphoprotein, ARPP-19.

Authors:  A Horiuchi; K R Williams; T Kurihara; A C Nairn; P Greengard
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

View more
  7 in total

1.  In memory of Victor Mutt. Discoveries of biologically important peptides.

Authors:  I Gozes
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

2.  Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19.

Authors:  Nina Irwin; Steven Chao; Luda Goritchenko; Atsuko Horiuchi; Paul Greengard; Angus C Nairn; Larry I Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

Review 3.  Genetics of neonatal hyperinsulinism.

Authors:  B Glaser; P Thornton; T Otonkoski; C Junien
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

4.  α-Endosulfine (ARPP-19e) Expression in a Rat Model of Stroke.

Authors:  Rupal I Mehta; Natalia Tsymbalyuk; Svetlana Ivanova; Jesse A Stokum; Kyoon Woo; Volodymyr Gerzanich; J M Simard
Journal:  J Neuropathol Exp Neurol       Date:  2017-10-01       Impact factor: 3.685

5.  Block of Ca(2+)-channels by alpha-endosulphine inhibits insulin release.

Authors:  Anne Virsolvy; Paul Smith; Gyslaine Bertrand; Laurent Gros; Lisa Héron; Guillermo Salazar; Raymond Puech; Dominique Bataille
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: molecular cloning, expression and biological properties.

Authors:  L Heron; A Virsolvy; K Peyrollier; F M Gribble; A Le Cam; F M Ashcroft; D Bataille
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.

Authors:  Sven Ivar Walaas; Hugh Caroll Hemmings; Paul Greengard; Angus Clark Nairn
Journal:  Front Neuroanat       Date:  2011-08-26       Impact factor: 3.856

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.